I completely agree - every concerned shareholder should

New Post Public Reply Private Reply Replies (1) Message Board
thesmalls
I completely agree - every concerned shareholder should write Bill and convey their thoughts directly with respect to this unprofessional behavior below. If Bill condones it - then it will make my decision easier to move on.

I normally wouldnt even address a post such as this but when it comes as, once again, another defensive attack from what isis supoosed to be an ambassador for the brand/shareholders - one should respond and let other shareholders decide for themselves what type of mouthpiece is best for the company.

- I am not a "basher." Far from it. I am a stockholder with well into 8 figures and a cost basis that was steadilysteadily increasing until recently. You dont want me to sell. PPS cant absorb the constant selling from VNDM now and which IR seems to have no answers for.

- My concern is (was?) directly with the handling of information or lack thereof with IR/muse. That seems to be rather obvious with most of the readers on here. The concerns seem genuinely mutual with the heart of my issues. If you take that as "bashing" then you/your organization need to really brush up on your understanding of the OTC dynamics, manipulation, and what real "bashers" do and how they manipulate. Based on the preponderence of evidence and circumstance combined with the stock price before/after IR took over and the emergence of dilutive MMs - it looks more like a "pump n dump" on your part than bashing on mine. DD and asking for direct answers in a public disclosure format IS NOT bashing. It is due diligence which is even more critical in this realm. You are a penny stock that is now back in trips - NOT a blue chip. Understand the difference.

- You /the company STILL refuse to address the critical questions that have been asked and "skirted" around and caused myself and others to show public concern:

1. What is the name of your firm? (Why in the world would this be confidential - goes sfraight to credibility and transparency for investors)

2. How are you compensated? This goes straight to bias/vested interest. Very straightforward and you have given conflicting answers. This should NOT be a secret. Goes straight to credibility based on bias. Granted - paid agents of former toxic lenders were disruptive of CCs, Timken, etc.

3. Guidance on revenue. Again - very different from what you are responding to. Bill provided very specific goals/targets in biz plan that has since been abolished and being reconstructed in 90 day plan. What is 2016 year end guidance range and/or when will IR/company provide it. Announcing SLAs 12-24 months out that may or may not come to fruition is NOT the same as saying: "We expect revenues to be between $500K and $2.5MM in 2016. Tighter guidance is not prudent at this time due to the nature of being a start up and the switching of revenue generation from in house to 3rd party licensing/SLA agreements." Straightforward. Real numbers. Not esoteric numbers with no definitive terms or contracts with teeth. Why is this difficult? Why keep ignoring the real question? I have been specific. Bill gave a 5 year revenue projection in biz plan along with decreasing OS that many long term investors considered the "fundamentals ". What are those new fundamentals and/or when will they specifically be updated? If these agreements and deals are specific in terms of start dates and production values - baselines should be straightforward on the minimum side of guidance.

I will address others later due to time constraints now.

You are quickly losing credibility trying to dismiss my valid concerns by lumping me in with them is rather silly when looking at my entire posting history here and elsewhere let alone completely unprofessional and flat out wrong. Worse, when you have an actual, long term investor that has been rather complimentary to the company at large over the last 12-24 months ask critical questions and then lambast me as a basher - you actually provide easy fodder for the real detractors on iLie to have a field day with your comments. If you arent going to address the specific questions and concerns above - do us all a favor and say nothing. I and other long term shareholders that i personally correspond with cant help but notice the direct correlation between the stock price and your emergence. Worse, the price spike prior to VNDM showing up and continually unloading shares driving the price down (again - fodder for the P&D argument).

For other concerned shareholders, I suggest you write to CEO directly if you find this type of response unproductive, unprofessional, and counter intuitive to the role that seems to be regular IR groups. Alienating long term investors with critical questions is NOT conducive to fostering respect, loyalty, and creating long term holders. Having me sell and move on tanks the price and forces others to sell. That imbalance from a large shareholder leaving becomes easy fodder for MM to naked short with little risk. How exactly does that strengthen the company and/or help shareholders...?

Again - if you are concerned as I am - go to Bill directly.



"Greetings TPAC Shareholders.

There are “shareholder concern” posts on places like IHUB and now Investors Hang Out. (In particular addressing the alias – thesmalls-- on Investors Hangout)

The post states that TPAC/IR skirts around revenue inquiries (among a list of other things that won’t be addressed here). This is so far from the truth. The IH subscriber that posted such information has made inaccurate and false accusations. The post stated that there is a disconnect. I would like for this to truly be a disconnect but I am now sure it isn’t.

It has been approved by CEO Bill McKay, as of May 4th, that IR can release deal structure information for the following forms of business dealings during the reconstruction:

• All contracts, of type purchase orders, Licensing Agreements, Service Level Agreements, PF Share agreements/distributions and OS structure information.

IR has tweeted that we could not extract information prior to the reconstruction period however since then we have provided direct information when requested for:
• O/S directly from the TA
• Deal structure including revenue time frame Licensing Agreement
• Deal Structure including revenue time frame Service Level Agreement

The revenue standard has been lowered from $250K to $75K (which should be restored)

IR has even provided news on Request for Quotes.

This is a new standard for TPAC"

Trans-Pacific Aerospace (TPAC) Stock Research Links

TPAC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 350

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 233

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 165

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 311

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 182

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 162

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 213

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 411

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading

Top 5 Most Recently Viewed Articles

Insmed to Discuss Financial Results in Upcoming Conference Call

Updated Category News Views 149

Insmed Financial Results Conference Call Announcement Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on delivering innovative therapies, has announced an important event for investors and stakeholders. The company is set to release its second-quarter financial results, and the details are crucial for those following its progress in the healthcare...

Continue Reading
Rathbones Group Plc Details on Renewi Plc Securities Disclosure

Updated Category News Views 202

Important Disclosure on Securities Related to Renewi Plc Understanding corporate disclosures is crucial for investors and stakeholders in any market. This article aims to highlight significant details surrounding Rathbones Group Plc's interest in the securities of Renewi Plc, a leading player in the waste management industry. Rathbones, known for its long-standing...

Continue Reading
Nuo Therapeutics Teams Up with Smith+Nephew for Innovative Wound Care Solutions

Updated Category News Views 436

Nuo Therapeutics Signs Exclusive Distribution Deal with Smith+Nephew Nuo Therapeutics, Inc. (OTCQB: AURX) has recently made headlines with the announcement of a significant private label distribution agreement with Smith+Nephew, a leader in medical technology. This partnership marks an exciting new chapter for Nuo, as it strategically positions itself within the advanced...

Continue Reading
Russia's Ambitious Plan to Enhance Baltic Sea Ports by 2030

Updated Category News Views 266

So, here’s the scoop: Russia’s flexing its muscles on the global stage by ramping up its Baltic Sea port capabilities. They’re not just kicking back and letting things unfold; they’ve got a plan to jack up their agricultural exports by a whopping 50% by 2030. This move isn’t merely about exporting more wheat; it’s a strategic pivot aimed at cutting down...

Continue Reading
Collaborating for a Greener Future: Univers and Microsoft Join Forces

Updated Category News Views 189

Univers Partners with Microsoft to Transform Energy Efficiency Univers, a global pioneer in artificial intelligence and Internet of Things (IoT) technology dedicated to energy solutions, has made waves by announcing a new partnership with Microsoft. This collaboration aims to catalyze the shift towards sustainable energy using innovative AI and cloud solutions. Setting...

Continue Reading